Ignite Creation Date:
2025-12-24 @ 1:43 PM
Ignite Modification Date:
2026-04-08 @ 4:32 AM
Study NCT ID:
NCT00080795
Status:
COMPLETED
Last Update Posted:
2012-10-22
First Post:
2004-04-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium
Sponsor:
M.D. Anderson Cancer Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000355361
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |